This month’s journal-based CME article is titled "Is Long Term Anticoagulation Required after Stent Placement for Benign Superior Vena Cava Syndrome?".
Studies investigating anticoagulation and venous stents have primarily focused on iliocaval stents. There is no consensus on post-procedural long-term anticoagulation even though patients may be anticoagulated after stent placement for benign superior vena cava (SVC) syndrome. This study provides data on long-term anticoagulation on symptom relief and stent patency after stent placement for benign SVC syndrome.
This program is designed to meet the educational needs of interventional radiologists, cardiologists, vascular surgery, thoracic surgeons, nurses, techs, and trainees at all levels with special interest in HCC.
To receive CME credit for this journal-based CME activity, participants must read the journal article and score 75% or better on the post test. Participants will have three opportunities to score 75% or better.
After participating in this journal-based CME activity, learners should be able to
Describe common signs and symptoms of SVC syndrome
Cite the impact of anticoagulation on recurrent symptoms, signs and stent patency despite initial technical success.
Identify expected stent patency at various time points (6 months -4 years) for anti-coagulated and non-anticoagulated patients.
JVIR CME Editor
Nishita Kothary, MD
Stanford University Medical Center, Stanford CA
Mustafa Haddad, MD
Scott Thompson, MD, PhD
Ian McPhail, MD
Emily Bendel, MD
Manju Kalra, MBBS
Andrew Stockland, MD
Newton Neidert, MD
James Andrews, MD
Sanjay Misra, MD
Haraldur Bjarnason, MD
Melissa Neisen, MD
Mayo Clinic, Department of Radiology, Rochester, MN
Conflicts of Interest: None of the authors have identified a conflict of interest.
Disclosures: None of the authors have financial disclosures.
Scientific Advisor, Siemens Healthcare
This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME).
The Society of Interventional Radiology (SIR) is accredited by the ACCME to provide continuing medical education for physicians. SIR designates this education activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program is approved for 1 self-assessment CME credit (SA-CME) by the Society of Interventional Radiology (SIR) - approved November 1, 2018. SIR is awarded Deemed Status by the American Board of Radiology (ABR). The SA-CME credit offered for this enduring activity meets the ABR’s criteria for self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification (MOC) Program.